YM155 inhibits neuroblastoma growth through degradation of MYCN: A new role as a USP7 inhibitor.
Li X, Yang F, He N, Zhang M, Lv Y, Yu Y, Dong Q, Hou X, Hao Y, An Z, Zhang H, Yang Z, Zhai H, Guo D, Cao Z, Jiang VC, Chen Y.
Li X, et al. Among authors: yu y.
Eur J Pharm Sci. 2023 Feb 1;181:106343. doi: 10.1016/j.ejps.2022.106343. Epub 2022 Nov 24.
Eur J Pharm Sci. 2023.
PMID: 36436754
Free article.